RECRUITING

Glycemic Metrics and Patterns in People With and Without Prediabetes

Talk to us

Conditions

Pre Diabetes

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.

Official Title

Observation and Identification of Glycemic Metrics and Patterns in People With and Without Prediabetes (PREMAP)

Quick Facts

Study Start:2025-02-28
Study Completion:2026-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06921902

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Subject must be at least 18 years of age.
  2. * Subject must be willing and able to provide written signed and dated informed consent.
  1. * Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes.
  2. * Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment.
  3. * Subject is known to be pregnant at the time of enrollment.
  4. * Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin.
  5. * Subject is currently on any form of treatment indicated for the treatment of diabetes.
  6. * Subject is currently on any form of medication indicated for weight loss.

Contacts and Locations

Study Contact

MOHAMED NADA, PhD
CONTACT
5107495416
adc.clinical@abbott.com

Principal Investigator

Shridhara Karinka, PhD
STUDY_CHAIR
Abbott Diabetes Care

Study Locations (Sites)

Diabetes and Obesity Care
Bend, Oregon, 97702
United States

Collaborators and Investigators

Sponsor: Abbott Diabetes Care

  • Shridhara Karinka, PhD, STUDY_CHAIR, Abbott Diabetes Care

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-28
Study Completion Date2026-07

Study Record Updates

Study Start Date2025-02-28
Study Completion Date2026-07

Terms related to this study

Additional Relevant MeSH Terms

  • Pre Diabetes